Core Viewpoint - The company is undergoing a green transformation focused on low-carbon production and innovative green processes, leveraging synthetic biology and AI for future-oriented research and development [1] Group 1: Green Transformation - The company has established five production bases recognized as national or provincial green factories, with multiple processes included in the green low-carbon directory [1] - Significant reductions in energy and material consumption have been achieved through the transformation of green processes such as continuous and microchannel reactions [1] - The company has increased the proportion of green electricity through solar power generation and has implemented energy-saving upgrades and equipment renewal, as well as measures for water recycling and waste heat recovery, directly lowering operational and production costs [1] Group 2: New Quality Production Capacity - The company is one of the earliest developers of bio-fermentation pesticides in China, such as abamectin, and is proactively establishing synthetic biology laboratories and AI innovation platforms (Deyanzhichuang) [1] - Collaborations with industry giants like BASF and partnerships with top research institutions and advanced biotechnology companies aim to innovate from the source, developing the next generation of efficient and low-residue green pesticides [1]

Group 1 - The core announcement from Guangdong Guangkang Biochemical Technology Co., Ltd. involves specific shareholders planning to reduce their stakes in the company through centralized bidding and block trading within three months from the announcement date [1] - The shareholders, including Qiongcheng Huatuo Zhiying No. 2 Investment Partnership and Shenzhen Huatuo Zhiyuan No. 3 Investment Enterprise, plan to collectively reduce their holdings by up to approximately 1.7835% of the total share capital, which amounts to about 132,000 shares [1] - Another shareholder, Qiongcheng Ruihong Kaiyin No. 1 Equity Investment Fund Partnership, intends to reduce its stake by up to 198,000 shares, representing about 2.68% of the total share capital [1] Group 2 - The news also highlights a significant development in the video generation industry, where a Chinese video model is being referred to as the "strongest on earth," capable of generating 15-second videos for commercial delivery with just a few prompts [1] - This advancement has led to a surge in stock prices for film and television companies, indicating a positive market reaction to the technological innovation [1]

Core Viewpoint - Recent share reduction by senior executives of Xinong Co., Ltd. (002942) is primarily attributed to personal financial needs, with minimal impact on the company's governance and operational continuity [2][5]. Recent Events - Zhang Jianrong (Director and Executive) reduced his holdings by 439,588 shares (0.2820% of total shares) from December 8, 2025, to February 3, 2026, at an average price of 21.57 CNY per share, lowering his ownership to 1.1830% [2]. - Wang Zhanqin (Director and Executive) sold 4,000 shares (0.0026% of total shares) on February 9, 2026, with the stock price increasing by 1.41% on that day, closing at 21.65 CNY [2]. Impact of the Event - During Zhang Jianrong's selling period, the company's stock price fluctuated within a range of approximately 11.67% (from a low of 20.06 CNY to a high of 22.43 CNY), indicating stability without significant declines [3]. - Wang Zhanqin's sale did not exert downward pressure on the stock price, which even saw a slight increase, suggesting that small-scale reductions do not significantly affect market sentiment [3]. Company Fundamentals - Financial health is strong, with a debt-to-asset ratio of 27.43%, a current ratio of 2.24, and a quick ratio of 2.0, all exceeding industry averages, indicating robust short-term solvency [4]. - The company anticipates a year-on-year net profit growth of 50.71%-81.89% for 2025, with expected earnings between 87 million CNY and 105 million CNY, providing a solid foundation for performance recovery [4]. - The core business is resilient, with the formulation segment accounting for 49.71% in 2024, and products like thiazole zinc demonstrating technical barriers that align with the green trend in the pesticide industry [4]. Industry and Risk Analysis - High-level share reductions may be perceived as a lack of confidence by some investors; however, the small scale of the reductions, personal financial reasons, and positive company performance mitigate negative perceptions [5]. - The pesticide industry faces risks from environmental policies (e.g., "one certificate, one product") and fluctuations in raw material prices, with the company having 29 compliance risk records that necessitate attention to operational stability [5].

Group 1 - The implementation of the "one certificate, one product" policy is beneficial for companies with rich registration resources, scale advantages, and strong brand influence [2] - The policy raises the entry barriers in the domestic formulation industry, which is expected to further enhance industry concentration in the future [2] - The company currently holds a total of 328 various pesticide certificates, including 50 active ingredient registration certificates and 278 formulation registration certificates, covering multiple product categories such as fungicides, insecticides, herbicides, soil conditioners, and seed coatings [2] - With a rich registration resource base, the company can provide a one-stop application solution across multiple categories, which is expected to enhance the market competitiveness of its domestic formulation products [2] - The company will leverage its existing advantages in active ingredient varieties and focus on the development and brand enhancement of formulation products, aiming to create new flagship products and further enhance its brand influence [2]

Summary of Conference Call Notes Industry and Company Involved - The notes focus on the pesticide industry, specifically the production of K-amin (K胺) and its key intermediate, 2-nitro-3-methylbenzoic acid (2-硝体) [1][2][3][4]. Core Points and Arguments - **Incident Overview**: On February 7, an explosion occurred at Jiapeng Biotechnology Co., Ltd. in Shanxi Province, which was illegally producing 2-nitro-3-methylbenzoic acid under the guise of feed production. This incident resulted in 8 fatalities and has prompted the local government to intensify crackdowns on illegal small chemical factories [1][2]. - **Regulatory Impact**: The explosion is expected to lead to stricter regulations targeting underground factories involved in hazardous processes like nitration and oxidation, which are critical in the production of K-amin [2][4]. - **Key Intermediate**: 2-nitro-3-methylbenzoic acid is identified as a crucial bottleneck in the K-amin production chain. K-amin is synthesized from K-acid and K-amin using reagents like methanesulfonyl chloride, with 2-nitro-3-methylbenzoic acid being the starting material [2][3]. - **Price Trends**: The price of K-amin has remained stable in the range of 120,000 to 130,000 CNY over the past two years. Following the expiration of the patent for chlorantraniliprole, domestic companies are accelerating their market entry, leading to a decline in raw material prices from a peak of 2.5 million CNY to a low of 210,000 CNY by February 2025 [2][3]. - **Market Size**: K-amin is the world's largest pesticide, with a global sales scale nearing 2 billion USD as of 2023, corresponding to a demand of approximately 10,000 tons. The estimated compound annual growth rate (CAGR) for global demand from 2021 to 2027 is 4.4% [3]. - **Production Capacity**: Key producers and their capacities include: - Youdao Chemical: 11,000 tons (actual production ~3,000 tons) - Lier Chemical: 5,000 tons (actual production ~1,000 tons) - Hongtaiyang: 2,000 tons (actual production ~2,000 tons) - Zhongshan Chemical: 3,000 tons (actual production ~2,000 tons) - Chengxin: 3,000 tons (actual production ~2,000 tons) - Huilong Co.: 2,000 tons (expected to start production by the end of 2024) - Green Ba: Unspecified capacity (actual production >1,000 tons) - Fumeishi: 6,000 tons [3][4]. Other Important but Possibly Overlooked Content - **Beneficiary Companies**: The following companies are expected to benefit from the regulatory changes and market dynamics: - Guangkang Biochemical: 2,500 tons/year of K-amin, with plans to build and support 2-nitro-3-methylbenzoic acid production - Lianhua Technology: 5,000 tons/year of K-amin, supporting 2-nitro-3-methylbenzoic acid for Fumeishi - Beisimei: Capable of producing the isomer 3-nitro-2-methylbenzoic acid, which can be converted to 2-nitro-3-methylbenzoic acid - Hongtaiyang and Lier Chemical are also positioned to benefit from the tight supply of raw materials due to the ongoing production halt at Youdao Chemical [4].

Group 1 - The Ministry of Agriculture and Rural Affairs announced the first batch of 497 pesticide products for approval in 2026, reflecting current technological trends in the agrochemical industry and indicating a high-quality development path characterized by the concentration of high-end active ingredients, precision in formulation applications, and integrated green pest control [1][3] - Among the 37 active ingredient products, fungicides showed significant performance, with SDHI fungicides like Fluopyram and Fluazinam leading the registration numbers, confirming their core position in the market and industry due to their high efficiency and low risk [1][3] - Herbicides and insecticides displayed a trend of leading products and diverse component supplementation, with Sulfentrazone and Acetamiprid among the top registered ingredients, covering mainstream application scenarios such as dryland weeding and control of piercing-sucking pests [1][3] Group 2 - The announcement signals a quality upgrade in the industry, with companies like Shandong Binong Technology and Shaanxi Hengtian Bio-Agriculture achieving registration breakthroughs with higher content, setting new domestic product standards [1][3] - Products like Fluopyram and Prothioconazole are being directed for export to Europe and the United States, promoting the entry of domestic active ingredients into the international high-end market [1][3] - New plant growth regulators and elicitors such as S-elicitor and chitosan have been approved, aligning with the demand for green agriculture and increased resilience in crop production [1][3] Group 3 - Among the 460 formulation products, there have been breakthroughs in new combinations, new formulations, and new targets, with seed treatment agents entering a phase of tri-component combinations, achieving "one drug for multiple defenses" [2][4] - Bayer Crop Science introduced a tri-component seed treatment agent combining Fluazinam, Tebuconazole, and Imidacloprid for the first time to control aphids and root rot in wheat and corn, significantly broadening the scope of pest control [2][4] - The formulation combinations continue to evolve, with new combinations of Ethyl Multi-fungicide and diamide insecticides, as well as various combinations of Fluopyram, effectively delaying resistance and enhancing efficacy [2][4] Group 4 - New formulation types such as dispersible oil suspension agents and microencapsulated suspension agents are being introduced, promoting the upgrade of pesticides towards environmentally friendly and labor-saving solutions [2][4] - The registration of Fluindapyr for the control of aphids in watermelons further improves the product matrix for economic crop protection [2][4] - With the implementation of regulatory systems like "one certificate for one product," the industry is transitioning from quantity-based to quality-based competition, with leading companies focusing on the research and production capacity of high-end active ingredients [2][4]

Core Insights - Longhua Technology (联化科技) is positioned as a leading player in the agricultural and pharmaceutical CDMO sectors, with significant achievements in small nucleic acid CDMO and potential in functional chemicals [1][2] Business Overview - Longhua Technology has established a collaborative development framework across four core industrial segments: agricultural protection, pharmaceuticals, functional chemicals, and equipment & engineering services [2] - The agricultural protection segment generated revenue of 1.702 billion yuan in the first half of 2025, with a gross margin increase of 9.48% year-on-year [2] - The pharmaceutical segment, focusing on APIs and intermediates, achieved revenue of 1.018 billion yuan in the first half of 2025, reflecting a year-on-year growth of 42.80% [2] Small Nucleic Acid CDMO - The company is leveraging small nucleic acid CDMO to tap into new growth opportunities, with advantages over traditional small molecule and antibody drugs, including broader target selection and higher success rates [3] - Since 2022, the market for small nucleic acid drugs has seen significant activity, with 32 transactions totaling 29.022 billion USD in 2025, indicating strong commercial value [3] - Longhua Technology has developed scalable production processes for modified nucleotides and has established a high-efficiency delivery system for nucleic acid drugs, enhancing its competitive edge [3] Functional Chemicals and Market Potential - The functional chemicals segment reported revenue of 0.265 billion yuan in the first half of 2025, marking a year-on-year doubling [4] - The company is focusing on lithium battery materials, including lithium hexafluorophosphate and LiFSI, with ongoing product development in various testing phases [4] - The National Development and Reform Commission's new storage action plan aims for over 1.8 million kilowatts by 2027, which is expected to drive significant market demand in the energy storage sector [4] Financial Performance - For the first three quarters of 2025, Longhua Technology reported total revenue of 4.718 billion yuan, an increase of 8.25% year-on-year, and a net profit of 316 million yuan, surging by 871.65% [1] - The projected net profit for 2025 is estimated to be between 350 million and 420 million yuan, representing a year-on-year growth of 239.35% to 307.22% [4]

责任编辑：小浪快报 分红方面，泰禾股份A股上市后累计派现2.70亿元。 机构持仓方面，截止2025年9月30日，泰禾股份十大流通股东中，香港中央结算有限公司位居第六大流 通股东，持股23.02万股，相比上期减少17.17万股。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 2月6日，泰禾股份涨1.87%，成交额9132.31万元。两融数据显示，当日泰禾股份获融资买入额694.08万 元，融资偿还993.85万元，融资净买入-299.77万元。截至2月6日，泰禾股份融资融券余额合计6290.24 万元。 融资方面，泰禾股份当日融资买入694.08万元。当前融资余额6287.59万元，占流通市值的5.58%。 融券方面，泰禾股份2月6日融券偿还0.00股，融券卖出100.00股，按当日收盘价计算，卖出金额2946.00 元；融券余量900.00股，融券余额2.65万元。 资料显示，南通泰禾化工股份有限公司位于上海市长宁区临虹路365号北 ...

Group 1 - The core viewpoint is that there is no need to worry about short-term market fluctuations, as the underlying trends indicate a shift from virtual to real economies in Europe and the US, alongside the disruptive innovation brought by AI [2] - The urgency for strategic security investments and new infrastructure in the US reflects a growing competition, balancing short-term shareholder interests with long-term strategic value [2] - China's capital market has already completed the pricing adjustment from virtual to real, currently undergoing a verification and pricing process for quality and efficiency improvements [2] Group 2 - A potential "favorable timing and conditions" for a new upward cycle in the A-share market is anticipated in the coming months, particularly around the Spring Festival [3] - Historical data shows that February, especially around the Spring Festival, is a period of strong market activity, with small-cap stocks likely to outperform [3] - The recent market pullback is seen as an opportunity to regain confidence and prepare for the upcoming upward cycle, especially around the 4000-point level [3] Group 3 - The global market is quickly pricing in the potential hawkish stance of the Federal Reserve, while the Chinese government is shifting its focus towards domestic demand, which is expected to boost economic prospects [5] - The recent emphasis from the China Securities Regulatory Commission on stabilizing the capital market is expected to support a gradual recovery in the A-share market [5] - Recommendations include focusing on emerging technologies and sectors such as consumer services, food and beverage, and traditional manufacturing [5] Group 4 - The recent global asset adjustment is more about digesting emotions rather than fundamental changes, with a favorable environment for market recovery expected post-Spring Festival [6] - Key sectors to focus on include technology manufacturing, resource products, and infrastructure chains, with a particular emphasis on AI hardware and high-end manufacturing [6] - The upcoming period is expected to see increased industry catalysts and a rise in risk appetite, creating opportunities for thematic investments [6] Group 5 - The Hang Seng Technology Index is seen as having value for investment, with expectations of a rebound once the liquidity shock subsides [7] - The market is expected to experience a stronger performance post-Spring Festival, with a focus on sectors benefiting from the "14th Five-Year Plan" [7] - The rotation of investment focus is anticipated to accelerate in February, particularly towards sectors like oil, food and beverage, and construction materials [7] Group 6 - The global risk-off mode has led to a reevaluation of assets, with a focus on physical assets and a recovery in manufacturing trends [8] - Recommendations include investing in commodities like oil, copper, and lithium, as well as sectors with confirmed bottoming out in the Chinese manufacturing industry [8] - The return of capital and easing of pressure from quantitative tightening are expected to support a recovery in consumer sectors [8] Group 7 - The recent adjustments in the A-share market are primarily driven by internal factors, with external shocks having limited impact on the fundamental industry landscape [9][10] - The market sentiment has been sufficiently released, and a continuation of the spring market rally is anticipated post-Spring Festival [10] - Key sectors to watch include AI computing, chemical industries, and power equipment, with potential catalysts from local policy signals [10] Group 8 - The market is expected to maintain a range-bound oscillation, with a shift towards value and consumer sectors as high-valuation tech stocks face selling pressure [12] - Defensive sectors like banking and food and beverage are likely to attract investment, while growth sectors may regain focus post-Spring Festival [12] - The upcoming policy window and recovery in risk appetite are expected to shift market attention back to growth sectors with clear performance catalysts [12]

化工板块周五（2月6日）逆市猛攻。反映化工板块整体走势的化工ETF（516020）早盘低开后迅速拉 升，盘中场内价格最高涨幅达到3.45%，而后持续高位震荡，尾盘略有回落，最终逆市收涨2.37%。 成份股方面，锂电、磷化工、石化等板块部分个股涨幅居前。截至收盘，恩捷股份涨停，宏达股份、浙 江龙盛、天赐材料等大涨超6%，恒逸石化、荣盛石化、华峰化学等亦涨幅居前。 | | | | 分时 多日 1分 5分 15分 30分 60分 日 周 月 图8 | | | | | F9 盘前盘后 露加 九特 画球 工具 @ (2) > | | 44. TETF O | | 516020 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | DOG | | | | 516020Hz工ETF] 15:00 � 0.949 通款 0.022(2.37%) 均价 0.947 服交量 0.10PV 0.9491 | | | | | 2026/02/06 | 0 946 | | +0.022 +2.379 | | | | | | ...